RESEARCHERS from the
University of Washington/Seattle
have found that intranasal insulin,
may help to improve cognitive
functioning in Alzheimer’s
sufferers.
Over a four month period the
researchers trialed either a placebo
or 20 or 40 IU of daily intranasal
insulin treatments on 109 patients.
Those patients taking insulin
showed significant improvements
in cognitive and functional tests
(up to two months after the testing
concluded) compared to those who
were taking placebos.
“We believe that restoring
normal insulin function in the brain
may provide therapeutic benefits to
adults with Alzheimer’s,” said
researcher Suzanne Craft.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.